Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
12%
ALSO IN XPH
XPH
55
HOLDINGS
14%
ALSO IN XLV
SECTOR DRIFT (XLV minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.3% | 2.4% | 2.4% |
|
JOHNSON & JOHNSON | 10.3% | 2.2% | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 2.3% | 2.2% |
|
PFIZER INC | 2.7% | 2.0% | 2.0% |
|
ELI LILLY & CO | 14.4% | 2.0% | 2.0% |
XLV Overweight Relative to XPH
|
ELI LILLY & CO | 12.4% |
|
JOHNSON & JOHNSON | 8.1% |
|
ABBVIE INC | 7.1% |
|
UNITEDHEALTH GROUP INC | 4.6% |
|
AMGEN INC | 3.6% |
|
ABBOTT LABORATORIES | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
GILEAD SCIENCES INC | 3.2% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
MERCK & CO. INC. | 3.0% |
XLV Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.6% |
|
EDGEWISE THERAPEUTICS, INC. | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.4% |
|
ELANCO ANIMAL HEALTH, INC. | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
SUPERNUS PHARMACEUTICALS INC | -2.2% |
 |
JAZZ PHARMACEUTICALS PLC | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.1% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.1% |